title: Oral formulations of L-dopa and continuous dopaminergic stimulation.
authors.forename: Robert
authors.initials: R
authors.lastname: Iansek
authors.forename: Mary
authors.initials: M
authors.lastname: Danoudis
mesh_terms: D000818:Animals; D000978:Antiparkinson Agents / Q000627:therapeutic use*; D002230:Carbidopa / Q000627:therapeutic use*; D015259:Dopamine Agents / Q000008:administration & dosage*; D016503:Drug Delivery Systems; D005260:Female; D006801:Humans; D007980:Levodopa / Q000008:administration & dosage* / Q000627:therapeutic use*; D008297:Male; D010300:Parkinson Disease / Q000188:drug therapy*
chemical_list: D000978:Antiparkinson Agents; D015259:Dopamine Agents; D007980:Levodopa; D002230:Carbidopa